EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elevated low‐density lipoprotein cholesterol: An inverse marker of morbidity and mortality in patients with myocardial infarction

Jessica Schubert iD, Bertil Lindahl, Håkan Melhus, Henrik Renlund, Margrét Leosdottir, Ali Yari, Peter Ueda iD, Tomas Jernberg, Emil Hagström iD

Journal of Internal Medicine · 2023-11 · 294 (5) · 616-627

DOI: 10.1111/joim.13656 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Internal Medicine, online erschienen am 31.05.2023. Verfasst von Jessica Schubert und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Myocardial Infarction. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The incidence of atherosclerotic cardiovascular disease increases with levels of low‐density lipoprotein cholesterol (LDL‐C). Yet, a paradox may exist where lower LDL‐C levels at myocardial infarction (MI) are associated with poorer prognoses.

Objective

To assess the association between LDL‐C levels at MI with risk factor burden and cause‐specific outcomes.

Methods

Statin‐naive patients hospitalized for a first MI and registered in SWEDEHEART were included. Data were linked to Swedish registers. Primary outcomes were all‐cause mortality and nonfatal MI. Associations between LDL‐C and outcomes were assessed using adjusted proportional hazards models.

Results

Among 63,168 patients (median age, 66 years), the median LDL‐C level was 3.0 mmol/L (interquartile range 2.4–3.6). Patient age and comorbidities increased as LDL‐C decreased. During a median follow‐up of 4.5 years, 10,236 patients died, and 4973 had nonfatal MI. Patients with the highest LDL‐C had a lower risk of mortality (hazard ratio [HR] 0.75; 95% confidence interval [CI] 0.71–0.80). The risk of hospitalization for pneumonia, hip fracture, chronic obstructive pulmonary disease, and new cancer diagnosis was lower with higher LDL‐C (HR range, 0.40–0.81). Patients with the highest LDL‐C had a greater risk of recurrent MI (HR 1.16; 95% CI 1.07–1.26).

Conclusions

Patients with the highest LDL‐C levels at MI had the lowest incidence of mortality and morbidity. This seems to reflect lower age at MI, less underlying morbidities, paired with the modifiability of LDL‐C. However, supporting the causal association between LDL‐C and ischemic heart disease, elevated LDL‐C was simultaneously associated with an increased risk of nonfatal MI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionHumansAgedCholesterol, LDLCholesterolRisk FactorsMorbidity

Stichwörter der Autor:innen

atherosclerosischolesterollipid loweringmyocardial infarctionobservationalprevention

Substanzen

Cholesterol, LDLCholesterol

Autor:innen und Institutionen

  • Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Uppsala Clinical Research Center, Uppsala, Sweden.
  • Department of Cardiology, Skåne University Hospital, Malmö, Sweden.
  • Department of Clinical Sciences, Faculty of Medicine, Lund University, Malmö, Sweden.
  • Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden.
  • Department of Medicine, Clinical Epidemiology Division, Karolinska Institutet, Solna, Stockholm, Sweden.

ORCID-Profile: Jessica Schubert, Peter Ueda, Emil Hagström

Zitieren

APA

Schubert, J., Lindahl, B., Melhus, H., Renlund, H., Leosdottir, M., Yari, A., Ueda, P., Jernberg, T., & Hagström, E. (2023). Elevated low‐density lipoprotein cholesterol: An inverse marker of morbidity and mortality in patients with myocardial infarction. Journal of Internal Medicine, 294(5), 616-627. https://doi.org/10.1111/joim.13656

Vancouver

Schubert J, Lindahl B, Melhus H, Renlund H, Leosdottir M, Yari A, et al. Elevated low‐density lipoprotein cholesterol: An inverse marker of morbidity and mortality in patients with myocardial infarction. Journal of Internal Medicine. 2023;294(5):616-627. doi:10.1111/joim.13656

BibTeX
@article{Schubert2023,
  author = {Schubert, Jessica and Lindahl, Bertil and Melhus, Håkan and Renlund, Henrik and Leosdottir, Margrét and Yari, Ali and Ueda, Peter and Jernberg, Tomas and Hagström, Emil},
  title = {Elevated low‐density lipoprotein cholesterol: An inverse marker of morbidity and mortality in patients with myocardial infarction},
  journal = {Journal of Internal Medicine},
  year = {2023},
  volume = {294},
  number = {5},
  pages = {616--627},
  doi = {10.1111/joim.13656}
}
Kostenlos starten →